WEST PHARMACEUTICAL SERVICES, INC. Operating Cash Flow
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Operating Cash Flow of $213.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $124.00M, a 29.98% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $89.90M, a 30.53% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $251.10M, a 32.09% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $197.20M, a 9.49% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. net cash provided by (used in) operating activities for fiscal 2025 was $754.80M, a 15.52% increase from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. net cash provided by (used in) operating activities for fiscal 2024 was $653.40M, a 15.85% decline from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. net cash provided by (used in) operating activities for fiscal 2023 was $776.50M, a 7.25% increase from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. net cash provided by (used in) operating activities for fiscal 2022 was $724.00M, a 23.97% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $124.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $213.90M 10-Q · filed 2026-07-23 | $465.00M derived: sum of 3 quarters · filed 2026-07-23 | $662.20M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $89.90M 10-Q · filed 2026-04-23 | $341.00M derived: sum of 2 quarters · filed 2026-04-23 | $538.20M derived: sum of 3 quarters · filed 2026-04-23 | $715.30M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $251.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $448.30M derived: sum of 2 quarters · filed 2026-02-17 | $625.40M derived: sum of 3 quarters · filed 2026-07-23 | $754.80M 10-K · filed 2026-02-17 |
| 2025-09-30 | $197.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $374.30M derived: sum of 2 quarters · filed 2026-07-23 | $503.70M 10-Q · filed 2025-10-23 | $693.80M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $177.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $306.50M 10-Q · filed 2026-07-23 | $496.60M derived: sum of 3 quarters · filed 2026-07-23 | $676.70M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $129.40M 10-Q · filed 2026-04-23 | $319.50M derived: sum of 2 quarters · filed 2026-04-23 | $499.60M derived: sum of 3 quarters · filed 2026-04-23 | $664.60M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | $190.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $370.20M derived: sum of 2 quarters · filed 2026-02-17 | $535.20M derived: sum of 3 quarters · filed 2026-02-17 | $653.40M 10-K · filed 2026-02-17 |
| 2024-09-30 | $180.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $345.10M derived: sum of 2 quarters · filed 2025-10-23 | $463.30M 10-Q · filed 2025-10-23 | $702.40M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $165.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24 | $283.20M 10-Q · filed 2025-07-24 | $522.30M derived: sum of 3 quarters · filed 2026-02-17 | $752.40M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $118.20M 10-Q · filed 2025-04-24 | $357.30M derived: sum of 2 quarters · filed 2026-02-17 | $587.40M derived: sum of 3 quarters · filed 2026-02-17 | $756.60M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $239.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $469.20M derived: sum of 2 quarters · filed 2026-02-17 | $638.40M derived: sum of 3 quarters · filed 2026-02-17 | $776.50M 10-K · filed 2026-02-17 |
| 2023-09-30 | $230.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | $399.30M derived: sum of 2 quarters · filed 2024-10-24 | $537.40M 10-Q · filed 2024-10-24 | $768.20M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $169.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | $307.30M 10-Q · filed 2024-07-25 | $538.10M derived: sum of 3 quarters · filed 2025-02-18 | $707.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $138.10M 10-Q · filed 2024-04-25 | $368.90M derived: sum of 2 quarters · filed 2025-02-18 | $537.80M derived: sum of 3 quarters · filed 2025-02-18 | $710.90M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $230.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $399.70M derived: sum of 2 quarters · filed 2025-02-18 | $572.80M derived: sum of 3 quarters · filed 2025-02-18 | $724.00M 10-K · filed 2025-02-18 |
| 2022-09-30 | $168.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $342.00M derived: sum of 2 quarters · filed 2023-10-26 | $493.20M 10-Q · filed 2023-10-26 | $654.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $173.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $324.30M 10-Q · filed 2023-07-27 | $485.10M derived: sum of 3 quarters · filed 2024-02-20 | $675.20M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $151.20M 10-Q · filed 2023-04-27 | $312.00M derived: sum of 2 quarters · filed 2024-02-20 | $502.10M derived: sum of 3 quarters · filed 2024-02-20 | $646.50M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $160.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $350.90M derived: sum of 2 quarters · filed 2024-02-20 | $495.30M derived: sum of 3 quarters · filed 2024-02-20 | $584.00M 10-K · filed 2024-02-20 |
| 2021-09-30 | $190.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $334.50M derived: sum of 2 quarters · filed 2022-10-27 | $423.20M 10-Q · filed 2022-10-27 | $571.90M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $144.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | $233.10M 10-Q · filed 2022-07-28 | $381.80M derived: sum of 3 quarters · filed 2023-02-21 | $500.40M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $88.70M 10-Q · filed 2022-04-28 | $237.40M derived: sum of 2 quarters · filed 2023-02-21 | $356.00M derived: sum of 3 quarters · filed 2023-02-21 | $504.10M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $148.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $267.30M derived: sum of 2 quarters · filed 2023-02-21 | $415.40M derived: sum of 3 quarters · filed 2023-02-21 | $472.50M 10-K · filed 2023-02-21 |
| 2020-09-30 | $118.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $266.70M derived: sum of 2 quarters · filed 2021-10-28 | $323.80M 10-Q · filed 2021-10-28 | $430.20M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $148.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $205.20M 10-Q · filed 2021-07-30 | $311.60M derived: sum of 3 quarters · filed 2022-02-22 | $419.70M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $57.10M 10-Q · filed 2021-04-30 | $163.50M derived: sum of 2 quarters · filed 2022-02-22 | $271.60M derived: sum of 3 quarters · filed 2022-02-22 | $376.70M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $106.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $214.50M derived: sum of 2 quarters · filed 2022-02-22 | $319.60M derived: sum of 3 quarters · filed 2022-02-22 | $367.20M 10-K · filed 2022-02-22 |
| 2019-09-30 | $108.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | $213.20M derived: sum of 2 quarters · filed 2020-10-23 | $260.80M 10-Q · filed 2020-10-23 | $334.00M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $105.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-24 | $152.70M 10-Q · filed 2020-07-24 | $225.90M derived: sum of 3 quarters · filed 2021-02-23 | $314.30M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $47.60M 10-Q · filed 2020-04-24 | $120.80M derived: sum of 2 quarters · filed 2021-02-23 | $209.20M derived: sum of 3 quarters · filed 2021-02-23 | $291.20M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $73.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $161.60M derived: sum of 2 quarters · filed 2021-02-23 | $243.60M derived: sum of 3 quarters · filed 2021-02-23 | $288.60M 10-K · filed 2021-02-23 |
| 2018-09-30 | $88.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $170.40M derived: sum of 2 quarters · filed 2019-10-29 | $215.40M 10-Q · filed 2019-10-29 | $296.90M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $82.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $127.00M 10-Q · filed 2019-07-29 | $208.50M derived: sum of 3 quarters · filed 2020-02-24 | $284.30M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $45.00M 10-Q · filed 2019-05-08 | $126.50M derived: sum of 2 quarters · filed 2020-02-24 | $202.30M derived: sum of 3 quarters · filed 2020-02-24 | $287.60M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $81.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $157.30M derived: sum of 2 quarters · filed 2020-02-24 | $242.60M derived: sum of 3 quarters · filed 2020-02-24 | $263.30M 10-K · filed 2020-02-24 |
| 2017-09-30 | $75.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $161.10M derived: sum of 2 quarters · filed 2018-10-30 | $181.80M 10-Q · filed 2018-10-30 | $253.60M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $85.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $106.00M 10-Q · filed 2018-07-31 | $177.80M derived: sum of 3 quarters · filed 2019-02-28 | $246.20M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $20.70M 10-Q · filed 2018-05-08 | $92.50M derived: sum of 2 quarters · filed 2019-02-28 | $160.90M derived: sum of 3 quarters · filed 2019-02-28 | $237.10M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $71.80M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $140.20M derived: sum of 2 quarters · filed 2019-02-28 | $216.40M derived: sum of 3 quarters · filed 2019-02-28 | $219.40M 10-K · filed 2019-02-28 |
| 2016-09-30 | $68.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $144.60M derived: sum of 2 quarters · filed 2017-10-31 | $147.60M 10-Q · filed 2017-10-31 | $215.60M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $76.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $79.20M 10-Q · filed 2017-08-01 | $147.20M derived: sum of 3 quarters · filed 2018-02-26 | $216.00M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $3.00M 10-Q · filed 2017-05-05 | $71.00M derived: sum of 2 quarters · filed 2018-02-26 | $139.80M derived: sum of 3 quarters · filed 2018-02-26 | $217.30M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $68.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $136.80M derived: sum of 2 quarters · filed 2018-02-26 | $214.30M derived: sum of 3 quarters · filed 2018-02-26 | $212.40M 10-K · filed 2018-02-26 |
| 2015-09-30 | $68.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $146.30M derived: sum of 2 quarters · filed 2016-10-31 | $144.40M 10-Q · filed 2016-10-31 | $190.40M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $77.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $75.60M 10-Q · filed 2016-08-01 | $121.60M derived: sum of 3 quarters · filed 2017-02-28 | $185.50M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | -$1.90M 10-Q · filed 2016-05-06 | $44.10M derived: sum of 2 quarters · filed 2017-02-28 | $108.00M derived: sum of 3 quarters · filed 2017-02-28 | $172.20M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $46.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $109.90M derived: sum of 2 quarters · filed 2017-02-28 | $174.10M derived: sum of 3 quarters · filed 2017-02-28 | $182.90M 10-K · filed 2017-02-28 |
| 2014-09-30 | $63.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $128.10M derived: sum of 2 quarters · filed 2015-11-02 | $136.90M 10-Q · filed 2015-11-02 | $205.70M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $64.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | $73.00M 10-Q · filed 2015-08-03 | $141.80M derived: sum of 3 quarters · filed 2016-02-26 | $195.10M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $8.80M 10-Q · filed 2015-05-06 | $77.60M derived: sum of 2 quarters · filed 2016-02-26 | $130.90M derived: sum of 3 quarters · filed 2016-02-26 | $210.40M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $68.80M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $122.10M derived: sum of 2 quarters · filed 2016-02-26 | $201.60M derived: sum of 3 quarters · filed 2016-02-26 | $220.50M 10-K · filed 2016-02-26 |
| 2013-09-30 | $53.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | $132.80M derived: sum of 2 quarters · filed 2014-11-03 | $151.70M 10-Q · filed 2014-11-03 | $221.50M derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-06-30 | $79.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $98.40M 10-Q · filed 2014-08-01 | $168.20M derived: sum of 3 quarters · filed 2015-02-25 | $219.80M derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-03-31 | $18.90M 10-Q · filed 2014-05-08 | $88.70M derived: sum of 2 quarters · filed 2015-02-25 | $140.30M derived: sum of 3 quarters · filed 2015-02-25 | $192.50M derived: sum of 4 quarters · filed 2015-02-25 |
| 2012-12-31 | $69.80M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $121.40M derived: sum of 2 quarters · filed 2015-02-25 | $173.60M derived: sum of 3 quarters · filed 2015-02-25 | $187.40M 10-K · filed 2015-02-25 |
| 2012-09-30 | $51.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | $103.80M derived: sum of 2 quarters · filed 2013-11-04 | $117.60M 10-Q · filed 2013-11-04 | $159.40M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $52.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | $66.00M 10-Q · filed 2013-08-05 | $107.80M derived: sum of 3 quarters · filed 2014-02-27 | $147.50M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $13.80M 10-Q · filed 2013-05-06 | $55.60M derived: sum of 2 quarters · filed 2014-02-27 | $95.30M derived: sum of 3 quarters · filed 2014-02-27 | $135.00M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $41.80M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $81.50M derived: sum of 2 quarters · filed 2014-02-27 | $121.20M derived: sum of 3 quarters · filed 2014-02-27 | $130.70M 10-K · filed 2014-02-27 |
| 2011-09-30 | $39.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $79.40M derived: sum of 2 quarters · filed 2012-11-05 | $88.90M 10-Q · filed 2012-11-05 | $136.10M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $39.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $49.20M 10-Q · filed 2012-08-06 | $96.40M derived: sum of 3 quarters · filed 2013-02-27 | $144.40M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $9.50M 10-Q · filed 2012-05-04 | $56.70M derived: sum of 2 quarters · filed 2013-02-27 | $104.70M derived: sum of 3 quarters · filed 2013-02-27 | $136.30M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $47.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $95.20M derived: sum of 2 quarters · filed 2013-02-27 | $126.80M derived: sum of 3 quarters · filed 2013-02-27 | $138.30M 10-K · filed 2013-02-27 |
| 2010-09-30 | $48.00M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-07 | $79.60M derived: sum of 2 quarters · filed 2011-11-07 | $91.10M 10-Q · filed 2011-11-07 | $143.70M derived: sum of 4 quarters · filed 2012-03-01 |
| 2010-06-30 | $31.60M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2011-08-08 | $43.10M 10-Q/A · filed 2011-08-08 | $95.70M derived: sum of 3 quarters · filed 2012-03-01 | $134.70M derived: sum of 4 quarters · filed 2012-03-01 |
| 2010-03-31 | $11.50M 10-Q · filed 2011-05-05 | $64.10M derived: sum of 2 quarters · filed 2012-03-01 | $103.10M derived: sum of 3 quarters · filed 2012-03-01 | |
| 2009-12-31 | $52.60M derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-01 | $91.60M derived: sum of 2 quarters · filed 2012-03-01 | $137.70M 10-K/A · filed 2012-03-01 | |
| 2009-09-30 | $39.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $85.10M 10-Q · filed 2010-11-05 | ||
| 2009-06-30 | $46.10M 10-Q · filed 2010-08-05 | |||
| 2008-12-31 | $135.00M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |